Department of Dermatology, Institute of Clinical Medicine, University of Tartu, Raja 31, 50417, Tartu, Estonia.
Dermatology Clinic, Tartu University Hospital, Tartu, Estonia.
Sci Rep. 2022 Sep 6;12(1):15125. doi: 10.1038/s41598-022-19508-7.
There is a lack of robust prevalence estimates of atopic dermatitis (AD) globally and trends over time due to wide variation of populations and age groups studied, different study methodologies and case definitions used. We sought to characterize 12-month AD prevalence across the life span and change over time in resource-rich countries focusing on population-based studies and using a standardized AD case definition. This systematic review was conducted according to PRISMA guidelines. Medline (Ovid), Embase, WOS core collection, Cinahl, and Popline were searched for studies published since inception through August 15, 2016. Studies were synthesized using random effects meta-analysis. Sources of heterogeneity were investigated using subgroup analyses and meta-regression. From 12,530 records identified, 45 studies met the inclusion criteria. Meta-analysis with random effects revealed the 12-month period prevalence of 9.2% (95% confidence interval 8.4-10.1%). The prevalence was significantly higher among 0-5-year-old children (16.2%; 95% confidence interval 14.2-18.7%) than in older age groups. Studies using a random sampling strategy yielded lower prevalence estimates than studies relying on other sampling methods. There was no clear time trend in AD prevalence over the period of 1992-2013.
由于研究人群和年龄组、研究方法和使用的病例定义存在广泛差异,导致目前全球范围内特应性皮炎(AD)的流行率及其随时间变化的趋势缺乏可靠数据。本研究旨在描述资源丰富国家在整个生命历程中 12 个月 AD 的流行率,并关注基于人群的研究和使用标准化 AD 病例定义,探讨其随时间的变化情况。本系统评价按照 PRISMA 指南进行。通过 Medline(Ovid)、Embase、WOS 核心合集、Cinahl 和 Popline 检索自成立以来至 2016 年 8 月 15 日发表的研究。采用随机效应荟萃分析对研究进行综合。采用亚组分析和荟萃回归探讨异质性来源。从 12530 条记录中,有 45 项研究符合纳入标准。采用随机效应荟萃分析发现,12 个月的流行率为 9.2%(95%置信区间 8.4-10.1%)。0-5 岁儿童的患病率(16.2%;95%置信区间 14.2-18.7%)显著高于其他年龄组。采用随机抽样策略的研究得出的患病率估计值低于依赖其他抽样方法的研究。1992-2013 年间,AD 的流行率没有明显的时间趋势。